Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Recap by typeshit. Post by Benjamin Bikman on X.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
He points to a November 2026 study he says suggests semaglutide and other GLP-1 drugs may help beyond diabetes and obesity in people with schizophrenia.
The FDA notice says the pharmacy can't assure the vials are sterile. Check the full details to see which compounded products are affected.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
Loading…